Szmyd, Radoslaw https://orcid.org/0000-0001-9066-5775
Casolin, Sienna https://orcid.org/0000-0003-0357-0909
French, Lucy https://orcid.org/0009-0007-5568-6651
Manjón, Anna G.
Walter, Melanie https://orcid.org/0000-0003-3241-522X
Cavalli, Léa
Nelson, Christopher B. https://orcid.org/0000-0002-0223-4121
Page, Scott G. https://orcid.org/0000-0002-4659-5543
Dhawan, Andrew https://orcid.org/0000-0002-5027-1277
Hau, Eric
Pickett, Hilda A. https://orcid.org/0000-0002-9840-4841
Gee, Harriet E. https://orcid.org/0000-0001-7397-8585
Cesare, Anthony J. https://orcid.org/0000-0002-0864-1254
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1106241, 2004430, 2004430)
Australian Medical Research Future Fund
Human Frontier Science Program
Westmead Charitable Trust Early Clinician-Researcher Grant, Sydney West Radiation Oncology Network
Article History
Received: 6 September 2023
Accepted: 14 October 2024
First Online: 13 January 2025
Competing interests
: H.A.P. is the co-founder and shareholder of Tessellate Bio. H.E.G. received an AstraZeneca honorarium unrelated to this research. The other authors declare no competing interests.